Adenocarcinoma Summary

Networked: 37102 relevant articles (1106 outcomes, 5005 trials/studies) for this Disease

Key Drugs and Agents for Adenocarcinoma

1. Fluorouracil (Carac) : 83 outcomes 261 studies in 991 results : FDA 33 Generic
   
2. gemcitabine : 57 outcomes 189 studies in 569 results : FDA 7
   
3. Cisplatin (Platino) : 54 outcomes 204 studies in 790 results : FDA 6 Generic
   
4. gefitinib (Iressa) : 38 outcomes 59 studies in 247 results : FDA 1
   
5. Paclitaxel (Taxol) : 29 outcomes 64 studies in 263 results : FDA 13 Generic
   
6. oxaliplatin (Eloxatin) : 28 outcomes 80 studies in 223 results : FDA 14 Generic
   
7. docetaxel (Taxotere) : 27 outcomes 75 studies in 210 results : FDA 3
   
8. Leucovorin (Folinic Acid) : 24 outcomes 94 studies in 238 results : FDA 6
   
9. Carboplatin (JM8) : 21 outcomes 43 studies in 128 results : FDA 29 Generic
   
10. Epidermal Growth Factor Receptor (EGF Receptor) : 19 outcomes 65 studies in 568 results : IBA
    

Diseases Related to Adenocarcinoma

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Carcinoma (Carcinomatosis)
4. Squamous Cell Carcinoma (Epidermoid Carcinoma)
5. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

Key Therapies for Adenocarcinoma

1. Drug Therapy (Chemotherapy) : 152 outcomes 346 studies in 2182 results
   
2. Radiotherapy : 51 outcomes 128 studies in 971 results
   
3. Heterologous Transplantation (Xenotransplantation) : 29 outcomes 67 studies in 502 results
   
4. Combination Drug Therapy (Combination Chemotherapy) : 17 outcomes 33 studies in 203 results
   
5. Pancreaticoduodenectomy : 16 outcomes 62 studies in 477 results